IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 2848-2854

  Norton, Sarah Kennedy ^a   Barnstein, Brian ^a   Brenzovich, Jennifer ^a   Bailey, Daniel P ^a   Kashyap, Mohit ^a   Speiran, Kelly ^a   Ford, Jill ^a   Conrad, Daniel ^a   Watowich, Stephanie ^b   Moralle, Matthew R ^c   Kepley, Christopher L ^c   Murray, Peter J ^d   Ryan, John J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 3; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROTEIN KINASE B; PROTEIN KINASE FYN; PROTEIN KINASE SYK; STAT3 PROTEIN; STAT5 PROTEIN; SYNAPTOPHYSIN; STAT3 PROTEIN, MOUSE;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY TEMPERATURE; CELL ACTIVATION; CELL FUNCTION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; DRUG POTENCY; GENE OVEREXPRESSION; HISTAMINE BLOOD LEVEL; HOMEOSTASIS; HUMAN CELL CULTURE; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MAST CELL; MEDIATOR; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; DRUG ANTAGONISM; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUE; TRANSGENIC MOUSE;

ANAPHYLAXIS; ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; DOWN-REGULATION; HUMANS; INTERLEUKIN-10; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, IGE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TISSUE CULTURE TECHNIQUES;

EID: 45749121689     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.2848     Document Type: Article

References (61)

1. Ryan, J. J., and T. F. Huff. 2003. Biology of mast cells. In Middleton's Allergy: Principles and Practice, Vol. 1. N. F. Adkinson, and E. Middleton, eds. Mosby, St. Louis, pp. 333-346.
2. Metz, M., A. M. Piliponsky, C. C. Chen, V. Lammel, M. Abrink, G. Pejler, M. Tsai, and S. J. Galli. 2006. Mast cells can enhance resistance to snake and honeybee venoms. Science 313: 526-530.
3. Gregory, G. D., M. Robbie-Ryan, V. H. Secor, J. J. Sabatino, Jr., and M. A. Brown. 2005. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 35: 3478-3486.
4. Nigrovic, P. A., B. A. Binstadt, P. A. Monach, A. Johnsen, M. Gurish, Y. Iwakura, C. Benoist, D. Mathis, and D. M. Lee. 2007. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc. Natl. Acad. Sci. USA 2325-2330.
5. Kelley, J. L., D. S. Chi, W. Abou-Auda, J. K. Smith, and G. Krishnaswamy. 2000. The molecular role of mast cells in atherosclerotic cardiovascular disease. Mol. Med. Today 6: 304-308.
6. Hara, M., K. Ono, M. W. Hwang, A. Iwasaki, M. Okada, K. Nakatani, S. Sasayama, and A. Matsumori. 2002. Evidence for a role of mast cells in the evolution to congestive heart failure. J. Exp. Med. 195: 375-381.
7. Rijnierse, A., A. S. Koster, F. P. Nijkamp, and A. D. Kraneveld. 2006. TNF-α is crucial for the development of mast cell-dependent colitis in mice. Am. J. Physiol. 291: G969-G976.
8. Lin, S., C. Cicala, A. M. Scharenberg, and J. P. Kinet. 1996. The FcεRIβ subunit functions as an amplifier of FcεRIγ-mediated cell activation signals. Cell 85: 985-995.
9. Rivera, J., and A. M. Gilfillan. 2006. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 117: 1214-1225.
10. Gilfillan, A. M., and C. Tkaczyk. 2006. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6: 218-230.
11. Barnstein, B. O., G. Li, Z. Wang, S. Kennedy, C. Chalfant, H. Nakajima, K. D. Bunting, and J. J. Ryan. 2006. Stat5 expression is required for IgE-mediated mast cell function. J. Immunol. 177: 3421-3426.
12. Kotenko, S. V. 2002. The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev. 13: 223-240.
13. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
14. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. J. Immunol. 157: 798-805.
15. Hunter, C. A., L. A. Ellis-Neyes, T. Slifer, S. Kanaly, G. Grunig, M. Fort, D. Rennick, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158: 3311-3316.
16. Berg, D. J., R. Kuhn, K. Rajewsky, W. Muller, S. Menon, N. Davidson, G. Grunig, and D. Rennick. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96: 2339-2347.
17. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177: 1205-1208.
18. Roers, A., L. Siewe, E. Strittmatter, M. Deckert, D. Schluter, W. Stenzel, A. D. Gruber, T. Krieg, K. Rajewsky, and W. Muller. 2004. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 200: 1289-1297.
19. Trachsel, E., F. Bootz, M. Silacci, M. Kaspar, H. Kosmehl, and D. Neri. 2007. Antibody-mediated delivery of interleukin-10 inhibits the progression of established collagen-induced arthritis. Arthritis Res. Ther. 9: R9.
20. Murray, P. J. 2006. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 6: 379-386.
21. Lin, T. J., and A. D. Befus. 1997. Differential regulation of mast cell function by IL-10 and stem cell factor. J. Immunol. 159: 4015-4023.
22. Marshall, J. S., I. Leal-Berumen, L. Nielsen, M. Glibetic, and M. Jordana. 1996. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. 97: 1122-1128.
23. Royer, B., S. Varadaradjalou, P. Saas, A. C. Gabiot, B. Kantelip, F. Feger, J. J. Guillosson, J. P. Kantelip, and M. Arock. 2001. Autocrine regulation of cord blood-derived human mast cell activation by IL-10. J. Allergy Clin. Immunol. 108: 80-86.
24. Royer, B., S. Varadaradjalou, P. Saas, J. J. Guillosson, J. P. Kantelip, and M. Arock. 2001. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy 31: 694-704.
25. Gillespie, S. R., R. R. DeMartino, J. Zhu, H. J. Chong, C. Ramirez, C. P. Shelburne, L. A. Bouton, D. P. Bailey, A. Gharse, P. Mirmonsef, et al. 2004. IL-10 inhibits FcεRI expression in mouse mast cells. J. Immunol. 172: 3181-3188.
26. Lang, R., R. L. Rutschman, D. R. Greaves, and P. J. Murray. 2002. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J. Immunol. 168: 3402-3411.
27. Koni, P. A., S. K. Joshi, U. A. Temann, D. Olson, L. Burkly, and R. A. Flavell. 2001. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 193: 741-754.
28. Takeda, K., T. Kaisho, N. Yoshida, J. Takeda, T. Kishimoto, and S. Akira. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161: 4652-4660.
29. Panopoulos, A. D., L. Zhang, J. W. Snow, D. M. Jones, A. M. Smith, K. C. El Kasmi, F. Liu, M. A. Goldsmith, D. C. Link, P. J. Murray, and S. S. Watowich. 2006. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 108: 3682-3690.
30. Ryan, J. J., S. DeSimone, G. Klisch, C. Shelburne, L. J. McReynolds, K. Han, R. Kovacs, P. Mirmonsef, and T. F. Huff. 1998. IL-4 inhibits mouse mast cell FcεRI expression through a STAT6-dependent mechanism. J. Immunol. 161: 6915-6923.
31. Schwartz, W., J. Jiao, J. Ford, D. Conrad, J. F. Hamel, P. Santanbien, L. Bradbury, and T. Robin. 2004. Application of chemically-stable immunoglobulin-selective sorbents: harvest and purification of antibodies with resolution of aggregate. BioProcessing J. 3: 53-62.
32. Ford, J. W., M. A. Kilmon, K. M. Haas, A. E. Shelburne, Y. Chan-Li, and D. H. Conrad. 2006. In vivo murine CD23 destabilization enhances CD23 shedding and IgE synthesis. Cell. Immunol. 243: 107-117.
33. Williams, L. M., U. Sarma, K. Willets, T. Smallie, F. Brennan, and B. M. Foxwell. 2007. Expression of constitutively active STAT3 can replicate the cytokine-suppressive activity of interleukin-10 in human primary macrophages. J. Biol. Chem. 282: 6965-6975.
34. El Kasmi, K. C., J. Holst, M. Coffre, L. Mielke, A. de Pauw, N. Lhocine, A. M. Smith, R. Rutschman, D. Kaushal, Y. Shen, et al. 2006. General nature of the STAT3-activated anti-inflammatory response. J. Immunol. 177: 7880-7888.
35. Lang, R., D. Patel, J. J. Morris, R. L. Rutschman, and P. J. Murray. 2002. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169: 2253-2263.
36. Hernandez-Hansen, V., A. J. Smith, Z. Surviladze, A. Chigaev, T. Mazel, J. Kalesnikoff, C. A. Lowell, G. Krystal, L. A. Sklar, B. S. Wilson, and J. M. Oliver. 2004. Dysregulated FcεRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. J. Immunol. 173: 100-112.
37. Odom, S., G. Gomez, M. Kovarova, Y. Furumoto, J. J. Ryan, H. V. Wright, C. Gonzalez-Espinosa, M. L. Hibbs, K. W. Harder, and J. Rivera. 2004. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med. 199: 1491-1502.
38. Hernandez-Hansen, V., G. A. Mackay, C. A. Lowell, B. S. Wilson, and J. M. Oliver. 2004. The Src kinase Lyn is a negative regulator of mast cell proliferation. J. Leukocyte Biol. 75: 143-151.
39. Mirmonsef, P., C. P. Shelburne, C. Fitzhugh Yeatman, 2nd, H. J. Chong, and J. J. Ryan. 1999. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3′--kinase. J. Immunol. 163: 2530-2539.
40. Thompson-Snipes, L., V. Dhar, M. W. Bond, T. R. Mosmann, K. W. Moore, and D. M. Rennick. 1991. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173: 507-510.
41. Defrance, T., B. Vanbervliet, F. Briere, I. Durand, F. Rousset, and J. Banchereau. 1992. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175: 671-682.
42. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D. H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89: 1890-1893.
43. Saini, S. S., and D. MacGlashan. 2002. How IgE upregulates the allergic response. Curr. Opin. Immunol. 14: 694-697.
44. Nishio, H., and K. Suzuki. 2004. Serum tryptase levels in sudden infant death syndrome in forensic autopsy cases. Forensic Sci. Int. 139: 57-60.
45. Echtenacher, B., D. N. Mannel, and L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77.
46. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381: 77-80.
47. Ryan, J. J., M. Kashyap, D. Bailey, S. Kennedy, K. Speiran, J. Brenzovich, B. Barnstein, C. Oskeritzian, and G. Gomez. 2007. Mast cell homeostasis: a fundamental aspect of allergic disease. Crit. Rev. Immunol. 27: 15-32.
48. Gomez, G., C. D. Ramirez, J. Rivera, M. Patel, F. Norozian, H. V. Wright, M. V. Kashyap, B. O. Barnstein, K. Fischer-Stenger, L. B. Schwartz, et al. 2005. TGF-β1 inhibits mast cell FcεRI expression. J. Immunol. 174: 5987-5993.
49. Bouton, L. A., C. D. Ramirez, D. P. Bailey, C. F. Yeatman, J. Yue, H. V. Wright, J. Domen, R. R. Rosato, S. Grant, K. Fischer-Stenger, and J. J. Ryan. 2004. Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion. Exp. Hematol. 32: 1137-1145.
50. Yeatman, C. F., 2nd, S. M. Jacobs-Helber, P. Mirmonsef, S. R. Gillespie, L. A. Bouton, H. A. Collins, S. T. Sawyer, C. P. Shelburne, and J. J. Ryan. 2000. Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J. Exp. Med. 192: 1093-1103.
51. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
52. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774.
53. Thienemann, F., B. M. Henz, and M. Babina. 2004. Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells. Arch. Dermatol. Res. 296: 134-138.
54. Beck, L. A., G. V. Marcotte, D. MacGlashan, A. Togias, and S. Saini. 2004. Omalizumab-induced reductions in mast cell FcεRI expression and function. J. Allergy Clin. Immunol. 114: 527-530.
55. MacGlashan, D. W., Jr., B. S. Bochner, D. C. Adelman, P. M. Jardieu, A. Togias, J. McKenzie-White, S. A. Sterbinsky, R. G. Hamilton, and L. M. Lichtenstein. 1997. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J. Immunol. 158: 1438-1445.
56. Gonzalez-Espinosa, C., S. Odom, A. Olivera, J. P. Hobson, M. E. Martinez, A. Oliveira-Dos-Santos, L. Barra, S. Spiegel, J. M. Penninger, and J. Rivera. 2003. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med. 197: 1453-1465.
57. Ilangumaran, S., and R. Rottapel. 2003. Regulation of cytokine receptor signaling by SOCS1. Immunol. Rev. 192: 196-211.
58. Hobbs, K., J. Negri, M. Klinnert, L. J. Rosenwasser, and L. Borish. 1998. Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma. Am. J. Respir. Crit. Care Med. 158: 1958-1962.
59. Palaniyandi, S. S., K. Watanabe, M. Ma, H. Tachikawa, M. Kodama, and Y. Aizawa. 2004. Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats. Eur. J. Immunol. 34: 3508-3515.
60. Kehrl, J. H. 2006. Chemoattractant receptor signaling and the control of lymphocyte migration. Immunol. Res. 34: 211-227.
61. Boyce, J. A. 2003. Mast cells: beyond IgE. J. Allergy Clin. Immunol. 111: 24-32.